Publication date: December 2026 Source: Molecular Metabolism, Volume 114 Author(s): Alexander Carbonell, Jarrad M. Scarlett, Ellie I. James, Kendra L. Francis, Kathryn Tyler, Tamim J. Chiba, Xavier Xong, Michael A. Haidar, Spoorthy Siddam, Aarun S. Hendrickson, Noah Marzouk, Cristiana J. Meuret, Caeley L. Bryan, Nina Brandt, Lauren E. Gilman, Jeremy M. Frey, Vladislav Baglaev, Mauricio D. Dorfman, David A. Tovar, Gregory J. Morton
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials